Balchem Corporation
BCPCBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeBalchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization,. The $5.05B market capitalization puts BCPC squarely in mid-cap range for its industry. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
Market Cap
$5.05B
Beta
0.85
P/E (TTM)
32.24
P/E (Fwd)
25.75
EPS (TTM)
$4.88
EPS (Fwd)
$6.11
ROE
12.7%
ROA
8.1%
Cash
$72.9M
Total Debt
$184.7M
Free CF
$138.1M
52W Change
-5.4%
Annual Financials
Cash vs Debt
On the balance sheet, BCPC has $72.9M in cash with $184.7M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $138.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 12.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $942.4M to $1.04B.
Investors considering Balchem Corporation should weigh the typical risks associated with BCPC's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing BCPC.